Growth 250 fell for the first time in five days, with declines in Astroscope ETC in Emerging Markets on the 2nd.

The Tokyo Stock Exchange Growth Market 250 Index fell for the first time in five days. Due to the prior continuous rise and the four-day weekend ahead, there was not much aggressive buying, but the decline was limited. Heartsheed <219A.T> and Astroscale Holdings <186A.T> were lower, while QPS Research Institute <5595.T> and GENDA <9166.T> were higher. Kaulis <153A.T> saw consecutive limit ups. The crash of Vortex <260A.T>, which had fully matched the previous day, rebounded sharply. Provided by WealthsA.

Kabushiki ShimbunMay 2 14:34

Advanced Reading Strategy Command Room = Heart Seed: Attention on the promising heart failure treatment progress, also gaining attention at the World Expo.

The biotech company Heartseed <219A.T> is likely to draw attention at the Osaka-Kansai Expo. It has developed "HS-001," which treats heart failure by injecting and transplanting allogeneic iPS cell-derived cardiomyocytes into the affected area through an open-heart surgery, regenerating and strengthening the cells to cure heart failure. Currently, there are 10 cases undergoing clinical trials, with 5 cases at a low dose and 5 cases at a high dose. The next generation product, "HS-005," will implant cardiomyocytes into the affected area via catheter without open-heart surgery, reducing the burden on patients.

Kabushiki ShimbunApr 15 08:32

CellSeed - temporarily reached the upper limit, with a rapid rise in Qualisys expanding interest in drug discovery-related stocks.

The stock reached a temporary high. Qualips <4894> announced its application for manufacturing and selling regenerative medicine products derived from iPS cell-derived cardiac muscle cell sheets, which has led to a surge in buying interest, reaching a stop-high buying indication, expanding into drug discovery-related stocks. Besides Cellseed, K Pharma <4896> and Heartseed <219A> are also rapidly rising. Cellseed disclosed the start of clinical trials for allogenic cartilage cell sheets on March 24, which seems to be attracting renewed buying interest.

Fisco JapanApr 9 12:22

Premium Stocks News = The theory of Prime Minister Ishiba's resignation is gaining strength, and attention is once again focused on "related to Takai."

The mutual tariffs announced by President Trump have sent shockwaves around the world. There is a fear that it could deal a significant blow to the Japanese economy, increasing the pressure on the Ishiba administration. Within the ruling Liberal Democratic Party, calls for the Prime Minister's resignation are openly surfacing, and the political situation may expand ahead of the July upper house elections. <Diplomatic difficulties and awareness of the upper house elections> At a meeting held on the 3rd by the 'Conservative Coalition,' composed of conservative members of the Liberal Democratic Party, demands for resignation were raised, stating 'We can't win the upper house elections with Prime Minister Ishiba.'

Kabushiki ShimbunApr 7 15:00

Premium Stock News = There are still stocks related to Takai, pay attention to the "National Dental Checkup for All Citizens."

Amid the issue of Prime Minister Ishiba distributing Commodity ETF vouchers to members of the National Diet, the related stocks of former Economic Security Minister Takai, seen as the strongest candidate for a post-Ishiba era, are surging due to speculative buying. A broader range of selections is also in sight. <Heart Seed is up 35%, along with Mark and others> Prime Minister Ishiba apologized for the distribution of the Commodity ETF vouchers but stated there is no illegality involved. However, the opposition parties are largely united in their stance that it violates regulatory laws and are preparing to pursue the matter. Calls questioning the Prime Minister's responsibility are also emerging within the ruling Liberal Democratic Party.

Kabushiki ShimbunMar 18 14:57

The Growth 250 continues to rise, with GENDA and others increasing = Emerging Markets, 17th.

The Tokyo Stock Exchange Growth Market 250 Index continued to rise. Following the increase in US stocks, the Tokyo market showed a strong trend, and the Growth 250 also maintained an upward trajectory. Companies such as Cover <5253.T>, Heartseed <219A.T>, and Genda <9166.T> saw increases, while Asiro <7378.T> and Ecomott <3987.T> experienced substantial gains. Timy <215A.T> declined. In the Standard segment, Maruchiyo Yamaoka <3399.T> was sold off. Provided by Wealth Advisor Co.

Kabushiki ShimbunMar 17 14:44